Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Vorinostat by Merck for Vulvar Cancer: Likelihood of Approval
Vorinostat is under clinical development by Merck and currently in Phase II for Vulvar Cancer. According to GlobalData, Phase II...
Vorinostat by Merck for Non-Small Cell Lung Cancer: Likelihood of Approval
Vorinostat is under clinical development by Merck and currently in Phase II for Non-Small Cell Lung Cancer. According to GlobalData,...
Vorinostat by Merck for Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma): Likelihood of Approval
Vorinostat is under clinical development by Merck and currently in Phase I for Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma). According to...
Vorinostat by Merck for Diffuse Large B-Cell Lymphoma: Likelihood of Approval
Vorinostat is under clinical development by Merck and currently in Phase I for Diffuse Large B-Cell Lymphoma. According to GlobalData,...
Vorinostat by Unravel Biosciences for Rett Syndrome: Likelihood of Approval
Vorinostat is under clinical development by Unravel Biosciences and currently in Phase I for Rett Syndrome. According to GlobalData, Phase...